May 3, 2024

News Collective

Complete New Zealand News World

Synchronization implants the first human brain chip, bypassing Neuralink - FayerWayer

Synchronization implants the first human brain chip, bypassing Neuralink – FayerWayer

Synchronization implanted Neuralink’s first human brain chip, Elon Musk’s company. He did it at Mount Sinai West, New York, led by Dr. Shahram Majidi.

Made by Dr. Tom Oxley Brain-computer interface (BCI) implantation using an endovascular approach, without the need for invasive open brain surgery, As part of the COMMAND trial.

“He’s an incredibly exciting teacher in this field, given his huge ramifications and potential,” Dr. Majidi explained in a statement. “The transplant went very well and the patient was able to go home 48 hours after the surgery.”

This is how the Synchron chip was implanted in the patient’s brain

The patient, whose name is withheld, suffers from severe paralysis. Thanks to the Synchron chip, you will be able to control digital devices without using your hands, bringing improvements in functional independence.

The person had a so-called Stentrode chip implanted within the brain’s motor cortex, via the jugular vein in a minimally invasive endovascular procedure.

The chip detects the intent of the motor and transmits it wirelessly, Using a special digital language to allow the patient to control their personal devices with just a gesture.

According to Synchron, a person will be able to send text messages and emails, shop online, and access healthcare services remotely.

“We are very excited to work with our patient, guiding them through the training process as they learn Use this device to live more independently and, most importantly, connect with family and friends.” Dr. David Putrino of Mount Sinai and principal investigator of the COMMAND study said.

See also  Solar Eclipse 2023 live: in which countries can it be seen and at what time | uses

Technology for the paralyzed

Neuralink’s competitor is headquartered in New York, It was founded in 2012 by Dr. Tom Oxley. “The first human implantation of intravascular BCI in the United States is an important clinical milestone that opens new possibilities for paralyzed patients,” Oxley said in the statement.

“Our technology is for the millions of people who have lost the ability to use their hands to control digital devices. We are excited about Introducing a scalable BCI solution to the market, One that has the power to change many lives.”